Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating venetoclax in combination with the CACAG regimen for newly diagnosed acute myeloid leukemia has completed enrollmen…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Music Therapy in Acute Leukemia Patients With Fatigue [NA]
A completed clinical trial evaluating music therapy for fatigue in patients with acute myeloid leukemia; results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Safety, Pharmacokinetics, and Preliminary Efficacy of BYON4413 in Acute Myeloid Leukemia and Myelodysplastic Neoplasms. [Phase 1]
A Phase 1 clinical trial of BYON4413 in relapsed/refractory acute myeloid leukemia and myelodysplastic neoplasms reports safety, pharmacokin…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: ONC-201 Maintenance Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome After Stem Cell Transplant [Phase 1]
Phase 1 trial of ONC-201 as maintenance therapy after stem cell transplant in acute myeloid leukemia and myelodysplastic syndromes has compl…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML [Phase 1]
A Phase 1 clinical trial is evaluating venetoclax in combination with intensive induction and consolidation chemotherapy in treatment-naïve …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies
The Orca-T Expanded Access Program study for patients with advanced hematologic malignancies has a status update. The study is temporarily n…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Velcade and Lenalidomide in Patients With Relapsed AML and MDS After Allogeneic Stem Cell Transplantation [Phase 1]
A Phase 1 trial evaluating Velcade (bortezomib) and lenalidomide in patients with relapsed myelodysplastic syndrome or acute myeloid leukemi…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML or HR-MDS [Phase 1]
Phase 1 clinical trial of CD64 CAR T cell therapy for adults with relapsed/refractory AML or high-risk MDS. The trial status is not yet recr…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Removing Transfusion Dependence as a Barrier to Hospice Enrollment [NA]
A completed clinical trial update indicates that transfusion dependence was removed as a barrier to hospice enrollment for patients with hem…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia [Phase 1]
Phase 1 trial evaluating mitoxantrone for venetoclax-resistant acute myeloid leukemia is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Extension Study, Pilot, Compassionate Use of Azacitidine 300 mg Film Coated Tablets for Acute Myeloid Leukaemia (AML) Patients [NA]
This clinical trial update covers an extension study, pilot, and compassionate-use program for azacitidine 300 mg film-coated tablets in pat…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Venetoclax to Augment Epigenetic Modification and Chemotherapy [Phase 1]
Phase 1 clinical trial evaluating venetoclax to augment epigenetic modification and chemotherapy in relapsed or refractory acute myeloid leu…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Trial Testing Safety of IL-21 NK Cells for Induction of R/R AML [Phase 1]
Phase 1 clinical trial completed evaluating the safety of IL-21–stimulated natural killer (NK) cells for induction in relapsed/refractory ac…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Decitabine and Cedazuridine in Combination With Venetoclax for the Treatment of Patients Who Have Relapsed Acute Myeloid Leukemia After Donor Stem Cell Transplant [Phase 2]
A Phase 2 trial of decitabine/cedazuridine with venetoclax for relapsed acute myeloid leukemia after donor stem cell transplant was terminat…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With an IDH2 Mutation [Phase 2]
Enasidenib is being studied for relapsed or refractory IDH2-mutant acute myeloid leukemia in a Phase 2 trial. The study status is Active Not…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Study of Regorafenib in Patients With Advanced Myeloid Malignancies [Phase 1]
This update reports on a Phase 1 study of regorafenib in patients with advanced myeloid malignancies, including acute myeloid leukemia; the …
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
Phase 1 dose-escalation study of Minnelide for relapsed or refractory acute myeloid leukemia was terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702) [NA]
A completed clinical trial update reporting long-term outcomes of alternative donor allogeneic transplantation across multiple hematologic d…
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: A Phase 1 Trial of CD25/Treg-depleted DLI Plus Ipilimumab for Myeloid Disease Relapse After Matched-HCT [Phase 1]
Phase 1 trial evaluating a combination of CD25/Treg-depleted donor lymphocyte infusion with ipilimumab for relapse of myeloid diseases after…
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: A Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]
A Phase 1/2 study evaluating gilteritinib in combination with chemotherapy for pediatric and young adult FLT3-ITD–positive relapsed/refracto…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Efficiency of Antibacterial Prophylaxis in Azacitidine Treated Patients [Phase 3]
Phase 3 trial evaluating antibacterial prophylaxis in azacitidine-treated patients has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients [Phase 1]
This document announces a Phase 1b trial of Lonitoclax in combination with azacitidine for Acute Myeloid Leukemia, and the study is currentl…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients [Phase 1, Phase 2]
The Phase 1/2 clinical study of CWP232291 in Acute Myeloid Leukemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN [Phase 1]
This Phase 1 trial update reports adding venetoclax to fludarabine and busulfan conditioning before transplant and to maintenance therapy fo…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old [Phase 2]
Phase 2 trial update of CPX-351 for secondary acute myeloid leukemia in patients under 60; the study is currently active but not recruiting,…